Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

MyVobo 0.2 M Tablet SR

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview MyVobo 0.2 M Tablet SR

Diabeva 0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults, effectively managing blood glucose levels. Diabeva 0.2mg Extended-Release Tablets should be taken with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects, such as nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are usually transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention; your physician can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your physician.

Primary Ingredients of MyVobo 0.2 M Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of MyVobo 0.2 M Tablet SR

Managing Type 2 diabetes

Major Benefits of MyVobo 0.2 M Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. MyVobo 0.2 M Tablet SR should be administered with a meal.

Common Side effects of MyVobo 0.2 M Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use MyVobo 0.2 M Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the MyVobo 0.2 M Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How MyVobo 0.2 M Tablet SR works:

MyVobo SR 200 mcg tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside MyVobo 0.2 M Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using MyVobo 0.2 M Tablet SR during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using MyVobo 0.2 M Tablet SR while breastfeeding is likely inadvisable. Preliminary research indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by MyVobo 0.2 M Tablet SR. Nevertheless, patients using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Patients with kidney impairment should use MyVobo 0.2 M Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates MyVobo 0.2 M Tablet SR use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of MyVobo 0.2 M Tablet SR in individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take MyVobo 0.2 M Tablet SR :

Should you forget a MyVobo 0.2 M Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About MyVobo 0.2 M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication
MyVobo 0.2 M Tablet SR
53
MRP 61
13% off